Live donor liver transplantation without blood products: Strategies developed for Jehovah's Witnesses offer broad application

Annals of Surgery

Volumn 240, Issue 2, 2004, Pages 350-357

  Jabbour, Nicolas ^a   Gagandeep, Singh ^a   Mateo, Rodrigo ^a   Sher, Linda ^a   Strum, Earl ^a   Donovan, John ^a   Kahn, Jeffrey ^a   Peyre, Christian G ^a   Henderson, Randy ^b   Fong, Tse Ling ^a   Selby, Rick ^a   Genyk, Yuri ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b USC UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERROUS SULFATE; FOLIC ACID ANTAGONIST; RECOMBINANT ERYTHROPOIETIN;

ADOLESCENT; ADULT; AGED; ALGORITHM; ARTICLE; BLEEDING; BLOOD AUGMENTATION; BLOOD STORAGE; BLOOD TRANSFUSION; CELL SALVAGE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ELECTIVE SURGERY; ERYTHROCYTE CONCENTRATE; ERYTHROPOIESIS; FEMALE; HEMATOCRIT; HEMODILUTION; HORMONAL REGULATION; HUMAN; INTENSIVE CARE UNIT; JEHOVAH'S WITNESS; LENGTH OF STAY; LIVE DONOR LIVER TRANSPLANTATION; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONOR; MALE; NORMOVOLEMIC HEMODILUTION; OPERATION DURATION; PORTOSYSTEMIC ANASTOMOSIS; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RELIGION; SALVAGE THERAPY; SURVIVAL; TECHNIQUE;

BLOOD TRANSFUSION; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; JEHOVAH'S WITNESSES; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONORS; MALE; POSTOPERATIVE CARE; PREOPERATIVE CARE; PROBABILITY; REFERENCE VALUES; RELIGION AND MEDICINE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 3242660849     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000133352.25163.fd     Document Type: Article

References (47)

1. Starzl TE, Demetriis AJ, Van Thiel D. Liver transplantation (1). N Engl J Med. 1989;321:1014-1022.
2. Starzl TE, Demetriis AJ, Van Thiel D. Liver transplantation (2). N Engl J Med. 1989;321:1092-1099.
3. Starzl TE, Demetriis AJ. Liver transplantation: a 31-year perspective. Part I. Curr Probl Surg. 1990;27:49-116.
4. Starzl TE, Demetriis AJ. Liver transplantation: a 31-year perspective. Part II. Curr Probl Surg. 1990;27:117-178.
5. Starzl TE, Demetriis AJ. Liver transplantation: a 31-year perspective. Part III. Curr Probl Surg. 1990;27:181-240.
6. United Network of Organ Sharing. 2000 Annual Report of the Scientific Registry of Transplant Recipients and the Organ Procurement and Transplantation Network: Transplant Data 1989-1998. Richmond, VA: United Network of Organ Sharing, February 2001.
7. Cohen B, Wight C. A European perspective on organ procurement: breaking down the barriers to organ donation. Transplantation. 1999;68:985-990.
8. Adamson J. Erythropoietin, iron metabolism, and red blood cell production. Semin Hematol. 1996;33(suppl 2):5-9.
9. Goldberg MA. Erythropoiesis, erythropoietin, and iron metabolism in elective surgery: preoperative strategies for avoiding allogeneic blood exposure. Am J Surg. 1995;170(suppl):37-43.
10. Jabbour N, Zajko AB, et al. Transjugular intrahepatic portosystemic shunt in patients with end-stage liver disease: results in 85 patients. Liver Transplant Surg. 1996;2:139-147.
11. Monk TG, Goodnough LT. Acute normovolemic hemodilution. Clin Orthop. 1998;357:74-81.
12. Matot I, Scheinin O, Jurim O, et al. Effectiveness of acute normovolemic hemodilution to minimize allogeneic blood transfusion in major liver resections. Anesthesiology. 2002;97:794-800.
13. Bak Z, AbildgArd L, Lisander B, et al. Transesophageal echocardiographic hemodynamic monitoring during preoperative acute normovolemic hemodilution. Anesthesiology. 2000;92:1250-1256.
14. Williamson KR, Taswell HF. Intraoperative blood salvage: a review. Transfusion. 1991;31:662-675.
15. Spain DA, Miller FB, et al. Quality assessment of intraoperative blood salvage and autotransfusion. Am Surgeon. 1997;63:1059-1063.
16. Kang YG, Martin DJ, Marquez J. Intraoperative changes in blood coagulation and thromboelastographic monitoring in liver transplantation. Anesth Analg. 1985;64:888-896.
17. Hendriks H, Meijer K, de Wolf JTM, et al. Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation: a pilot study. Transplantation. 2001;71:402-405.
18. Porte RJ, Molenaar IQ, Beligiomini B, et al. Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomized double-blind study. Lancet. 2000;355:1303-1309.
19. Tzakis A, Todo S, Starzl TE. Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg. 1989;210:L649-L652.
20. Marcos A. Right lobe live donor liver transplantation: a review. Liver Transplantation. 2000;6:3-20.
21. Trotter JF, Wachs ME, Gregory T, et al. Adult-to-adult transplantation of the right hepatic lobe from a living donor. N Engl J Med. 2002;346:1074-1082.
22. Cronin DC II, Millis JM, Siegler M. Transplantation of liver grafts from living donors into adults: too much, too soon. N Engl J Med. 2001;344:1633-1637.
23. Surman OS. The ethics of partial-liver donation. N Engl J Med. 2002;346:1038.
24. Gagandeep S, Jabbour N, Genyk Y, et al. Restricting fresh frozen plasma in hepatic resections. J Am Coll Surg. 2003;197:339-340.
25. Jabbour N, Gagandeep S, Mateo R, et al. Left portohepatic shunt: decreasing excessive portal venous inflow during live donor liver transplantation. J Am Coll Surg. 2003;197:1056-1057.
26. Ramos HC, Todo S, et al. Liver transplantation without the use of blood products. Arch Surg. 1994;129:528-533.
27. Snook NJ, O'Beirne HA, et al. Use of recombinant human erythropoietin to facilitate liver transplantation in a Jehovah's Witness. Br J Anaesth. 1996;76:740-743.
28. Seu P, Neelankanta G, Csete M, et al. Liver transplantation for fulminant hepatic failure in a Jehovah's Witness. Clin Transplant. 1996;10:404-407.
29. Detry O, Honore P, Delwaide J, et al. Liver transplantation in a Jehovah's Witness. Lancet. 1999;353:1680.
30. Jehovah's Witnesses. Perfect life: not just a dream (official publication of the Jehovah's Witnesses). Watchtower. 2000:29-31.
31. Schreiber MA, Holcomb JB, Hedner U, et al. The effect of recombinant factor VIIa on noncoagulopathic pigs with grade V liver injuries. J Am Coll Surg. 2003;196:691-697.
32. Hebert PC, Wells G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med. 1999;340:409-417.
33. Weiskopf RB, Viele MK, et al. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA. 1998;279:217-221.
34. Carson JL, Duff A, et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet. 1996;348:1055-1060.
35. Palomo Sanchez JC, Jimenez C, Moreno G, et al. Effects of intraoperative blood transfusion on post operative complications and survival after orthotopic liver transplantation. Hepatogastroenterology. 1998;45:1026-1033.
36. Miki C, Iriyama K, Gunson BK, et al. Influence of intraoperative blood loss on plasma levels of cytokines and endotoxin and subsequent graft liver function. Arch Surg. 1997;132:136-141.
37. Schroeder RA, Johnson LB, et al. Total blood transfusion and mortality after orthotopic liver transplantation. Anesthesiology. 1999;91:329-330.
38. Cacciarelli TV, Keefe EB, et al. Effect of intraoperative blood transfusion on patient outcome in hepatic transplantation. Arch Surg. 1999;134:25-29.
39. Schreiber GB, Busch T, Michael P, et al. The risk of transfusion- transmitted viral infections. N Engl J Med. 1996;334:1685-1690.
40. Goodnaugh LT, Brecher ME, et al. Transfusion medicine. N Engl J Med. 1999;340:438-447.
41. Goodnaugh LT, Brecher ME, et al. Medical progress: transfusion medicine (second of 2 parts): blood conservation. N Engl J Med. 1999;340:525-533.
42. Sloand EM, Pitt E, et al. Safety of the blood supply. JAMA. 1995;274:1368-1373.
43. Alter MJ, Druszon MD, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988-1994. N Engl J Med. 1999;431:556-562.
44. Finfer S, Howell S, Miller J, et al. Managing patients who refuse blood transfusions: an ethical dilemma. Major trauma in two patients refusing blood transfusion. Br Med J. 1994;308:1423-1424.
45. Sacks DA, Koppes RH. Caring for the female Jehovah's Witness: balancing medicine, ethics, and the First Amendment. Am J Obstet Gynecol. 1994;170:452-455.
46. Muramoto O. Jehovah's Witnesses and blood transfusions. Lancet. 1998;352:824.
47. Wilcox P. Jehovah's Witnesses and blood transfusion. Lancet. 1999;353:757-758.